Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Abstract Significance: The antiulcer peptide, stable gastric pentadecapeptide BPC 157 (previously employed in ulcerative colitis and multiple sclerosis trials, no reported toxicity (LD1 not achieved)), is reviewed, focusing on the particular skin wound therapy, incisional/excisional wound, deep burns, diabetic ulcers, and alkali burns, which may be generalized to the other tissues healing
The injection is administered intramuscularly or subcutaneously, typically 1-2 times per week as directed by your provider
Key Potential Research Applications*
The bottom line is that we needed replication of these ndings with additional studies to answer these and other questions
US$ 21.83
US$ 26.58
US$ 20.91
